Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing

SIMPLE SUMMARY: The aim of this study was to explore the utility of cascade family testing (CFT) in families of breast cancer patients who carry specific genetic variations. We conducted genetic analysis in a group of breast cancer patients and identified genetic variations in over 20% of them; thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Agiannitopoulos, Konstantinos, Potska, Kevisa, Katseli, Anastasia, Ntogka, Christina, Tsaousis, Georgios N., Pepe, Georgia, Bouzarelou, Dimitra, Tsoulos, Nikolaos, Papathanasiou, Athanasios, Ziogas, Dimitrios, Venizelos, Vassileios, Markopoulos, Christos, Iosifidou, Rodoniki, Karageorgopoulou, Sofia, Giassas, Stylianos, Natsiopoulos, Ioannis, Papazisis, Konstantinos, Vasilaki-Antonatou, Maria, Psyrri, Amanta, Koumarianou, Anna, Matthaios, Dimitrios, Zairi, Eleni, Blidaru, Alexandru, Banu, Eugeniu, Jinga, Dan Corneliu, Laçin, Şahin, Özdoğan, Mustafa, Papadopoulou, Eirini, Nasioulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649031/
https://www.ncbi.nlm.nih.gov/pubmed/37958392
http://dx.doi.org/10.3390/cancers15215218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649031/
https://www.ncbi.nlm.nih.gov/pubmed/37958392
http://dx.doi.org/10.3390/cancers15215218

Ejemplares similares